The Lighthouse | bear raids

Amarin Manipulation and Opportunity

By Erik Zimerman On June 25, 2013 · Add Comment · In Avvisi, The Whiskey Room

Amarin Corporation (AMRN), a pharmaceutical company that is currently marketing the recently approved Vascepa, is being offered at an almost outlandishly low share price. As the article is being written, Amarin (AMRN) is down around the 5.30’s, far below its previous 52-week low (before FDA approval). It is clear that short of some lurking, largely unknown phenomenon, Amarin has fallen prey to manipulation. Not implying any illegality, due to its infancy, and relatively small float, bear raids have been repeatedly successful in driving down the stock price, especially along with media “pieces” from the same circle of authors that continuously seem to push a curiously negative agenda surrounding the company and fall quite short of accurate or insightful. Currently, with a lull in big headlines and possible catalysts, the bear interest has succeeded in greatly depreciating the stock price, as the avalanche took with it retail investors that have despaired, given up, or were simply forced to sell due to margin calls as the stock price plummeted. The point of true success for any bear raid, is when the price fall gathers momentum on continues on by itself; this is when true profit is possible, as the bear raiders can [...]

[Continue Reading...]

S	M	T	W	T	F	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

Amarin Manipulation and Opportunity

Recent Posts

Top Posts & Pages

Halls

Archives

Subscribe to Blog via Email

Amarin Manipulation and Opportunity

Recent Posts

Top Posts & Pages

Tags

Halls

Archives

Subscribe to Blog via Email